ESTIMATING PROGNOSIS IN HIV-1 INFECTION

被引：11

作者：

PHAIR, JP ^{[1
]}

机构：

[1] NORTHWESTERN UNIV, SCH MED, CHICAGO, IL 60611 USA

来源：

ANNALS OF INTERNAL MEDICINE | 1993年 / 118卷 / 09期

关键词：

HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS-1; ACQUIRED IMMUNODEFICIENCY SYNDROME; OPPORTUNISTIC INFECTIONS ANTIGENS; CD4;

D O I：

10.7326/0003-4819-118-9-199305010-00015

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Progression of infection due to human immunodeficiency virus type 1 is highly variable. Clinical and laboratory measurements have been useful in establishing prognosis in a given patient. However, the CD4+ lymphocyte number, which has been used as the basis for all therapeutic decisions, has limitations. Virologic assays are assuming a larger role in predicting outcome in infected patients. New immunologic as well as virologic measures arc required to predict outcomes more accurately in these patients.

引用

收藏

页码：742 / 744

页数：3

相关论文

共 28 条

[1]

ANDERSON RM, 1988, J ACQ IMMUN DEF SYND, V1, P241

[2]

[Anonymous], 1992, MMWR Recomm Rep, V41, P1

[3] CD4+ LYMPHOCYTES ARE AN INCOMPLETE SURROGATE MARKER FOR CLINICAL PROGRESSION IN PERSONS WITH ASYMPTOMATIC HIV-INFECTION TAKING ZIDOVUDINE [J].

CHOI, SS ;

LAGAKOS, SW ;

SCHOOLEY, RT ;

VOLBERDING, PA .

ANNALS OF INTERNAL MEDICINE, 1993, 118 (09) :674-680

[4] DETECTION OF 3 DISTINCT PATTERNS OF T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS - INDEPENDENCE OF CD4+ CELL NUMBERS AND CLINICAL STAGING [J].

CLERICI, M ;

STOCKS, NI ;

ZAJAC, RA ;

BOSWELL, RN ;

LUCEY, DR ;

VIA, CS ;

SHEARER, GM .

JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :1892-1899

[5] THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].

FAHEY, JL ;

TAYLOR, JMG ;

DETELS, R ;

HOFMANN, B ;

MELMED, R ;

NISHANIAN, P ;

GIORGI, JV .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172

[6] ASSOCIATION OF ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CORE PROTEIN (P24), CD4+ LYMPHOCYTE NUMBER, AND AIDS-FREE TIME [J].

FARZADEGAN, H ;

CHMIEL, JS ;

ODAKA, N ;

WARD, L ;

POGGENSEE, L ;

SAAH, A ;

PHAIR, JP .

JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (06) :1217-1222

[7] QUANTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT MESSENGER-RNA AS A MARKER FOR ASSESSING THE EFFICACY OF ANTIRETROVIRAL THERAPY [J].

FURTADO, MR ;

MURPHY, R ;

WOLINSKY, SM .

JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01) :213-216

[8] EFFECT OF ZIDOVUDINE AND PNEUMOCYSTIS-CARINII PNEUMONIA PROPHYLAXIS ON PROGRESSION OF HIV-1 INFECTION TO AIDS [J].

GRAHAM, NMH ;

ZEGER, SL ;

PARK, LP ;

PHAIR, JP ;

DETELS, R ;

VERMUND, SH ;

HO, MT ;

SAAH, AJ .

LANCET, 1991, 338 (8762) :265-269

[9] QUANTITATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 IN THE BLOOD OF INFECTED PERSONS [J].

HO, DD ;

MOUDGIL, T ;

ALAM, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1621-1625

[10] DETECTION AND QUANTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS RNA IN PATIENT SERUM BY USE OF THE POLYMERASE CHAIN-REACTION [J].

HOLODNIY, M ;

KATZENSTEIN, DA ;

SENGUPTA, S ;

WANG, AM ;

CASIPIT, C ;

SCHWARTZ, DH ;

KONRAD, M ;

GROVES, E ;

MERIGAN, TC .

JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) :862-866